http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10874641

Ruiz A, Nadal M, Puig S, Estivill X.
“Cloning of the human phospholipase A2 activating protein (hPLAP) gene on the chromosome 9p21 melanoma deleted region”
Gene 239: 155-161 (1999)

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1057104

S Puig, J Castro, PJ Ventura, C Ascaso, J Malvehy, X Estivill, A Vilalta, M Lecha, T Castel.
“Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases”
Melanoma Research; 10: 231-236 (2000)

Moral A, Lafuente MJ, Lafuente A, Castel T, Balesta AM, Lecha M; Trias M, The MMM Group.
The Use Erytrocyte Glutathione as a predictive marker for malignant melanoma.
Anticancer Research 20: 4757-4760 (2000)

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11205213

Rizos H*, Puig S*, Badenas C, Malvehy J, Darmanian AP, Jiménez L, Milà M, Kefford RF.
A melanoma-associated germline mutation in exon 1ß inactivates p14ARF.
Oncogene 20: 5543-7 (2001)

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11571653

C Ferrandiz, Bordas X, García-Patos V, Puig S, Pujol R, Smandia A.
Prevalence of Psoriasis in Spain.
EJAD 15: 20-23 (2001)

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11451315

E Serra, E Ars, A Ravella, A Sanchez, S Puig, T Rosenbaum, X Estivill, C Lazaro.
Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
Human Genet 108: 416-429 (2001)

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11409870

Asumalahti K, Veal C, Laitinen T, Suomela S, Allen M, Elomaa O, Moser M, de Cid R, Ripatti S, Vorechovsky I, Marcusson JA, Nakagawa H, Lazaro C, Estivill X, Capon F, Novelli G, The psoriasis consortium, et al.
Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus.
Hum Mol Genet 2002; 11: 589-597.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11875053

Kefford R, Bishop JN, Tucker M, Bressac-de Paillerets B, Bianchi-Scarra G, Bergman W, Goldstein A, Puig S, Mackie R, Elder D, Hansson J, Hayward N, Hogg D, Olsson H.
Genetic testing for melanoma.
Lancet Oncol (2002) 3:653-654

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12424065

Malvehy J, Puig S.
“Follow up of melanocytic skin lesions with digital dermoscopy”.
Clin Dermatol (2002) 20:297-304

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12074871

Vidal-Sicart S, Pons F, Puig S, Ortega M, Vilalta A, Martín F, Rull R, Palou J, Castel T.
Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?
Eur J Nucl Med Mol Imaging 2003; 30(3):362-6

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12634963

Vilella R, Benitez D, Mila J, Vilalta A, Rull R, Cuellar F, Conill C, Vidal-Sicart S, Costa J, Yachi E, Palou J, Malvehy J, Puig S, Martí R, Mellado B, Castel T.
Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine.
Int J Cancer 2003 Sep 10; 106(4):626-31.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12845663

Argenziano G, Soyer HP, Chimenti S, Malvehy J, Puig S et al.
Dermoscopy of pigmented skin lesions. Results of a Consensus Meeting via Internet.
J Am Acad Dermatol (2003) 48: 679-93

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12734496

Yakobson E, Eisenberg S, Isacson R, Halle D, Levy-Lahad E, Catane R, Safro M, Sobolev V, Huot T, Peters G, Ruiz A, Malvehy J, Puig S, Chompret A, Avril MF, Shafir R, Peretz H, Paillerets BB. Eur J
A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.
Hum Genet. 2003 Apr;11(4):288

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12700603

Zalaudek I, Argenziano G, Ferrara G, Soyer HP, Corona R, Sera F, Cerroni L, Carbone A, Chiominto A, Cicale L, De Rosa G, Ferrari A, Hoffmann-Wellenhof R, Malvehy J, Peris K, Pizzichetta MA, Puig S, Scaqlvenzi M, Staibano S and Ruocco V.
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathologycal study.
Br J Dermatol (2004) 150: 64-71

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14746618

Malvehy J, Puig S.
Dermoscopic Patterns of benign volar melanocytic lesions in patients with atypical mole syndrome.
Arch Dermatol (2004) 140: 538-44

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15148097

Conill C, González-Cao M, Jorcano S, Puig S, Malvehy J, Martí R and Castel T.
Temozolomide as profilaxis of melanoma brain metastases.
Mel Res 2004: 14; 73-4

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15091198

R. Vilella, D. Benítez, J. Milà, M. Lozano, R. Vilana, J. Pomes, X. Tomas, J. Costa, A. Vilalta, J. Malvehy, S. Puig, B. Mellado, R. Martí and T. Castel.
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate.
Cancer immunology immunotherapy 2004; 53: 651-8

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14999431

Zalaudek I, Argenziano G, Leinweber B, Luigi Citarella,3 MD; Rainer Hofmann-Wellenhof,1 MD; Josep Malvehy,4 MD; Susana Puig,4 MD; Maria Antonietta Pizzichetta,5 MD; Luc Thomas,6 MD; H. Peter Soyer,1 MD; H. Kerl,1 MD
Dermoscopy OF Bowen´s disease.
Br J Dermatol 2004; 150: 64-71

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15214896

Gonzalez Cao M, Puig S, Mellado B.
Survivin expression in sentinel lymp nodes from melanoma patients.
J Clin Oncol 2004; 22: 2751-2

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15226347

Vidal-Sicart S, Pons F, Fuertes S, Vilalta A, Rull R, Puig S, Palou J, Ortega M, Castel T.
Is the identification of in transit sentinel lymph nodes in malignant melanoma patients really necessary?
Eur J Nucl Med Mol Imaging 2004; 31: 945-9

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14997348